tradingkey.logo
搜尋

Polyrizon Ltd

PLRZ
添加自選
14.800USD
-0.220-1.46%
收盤 05/15, 16:00美東報價延遲15分鐘
26.39M總市值
虧損本益比TTM

Polyrizon Ltd

14.800
-0.220-1.46%

關於 Polyrizon Ltd 公司

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..

Polyrizon Ltd簡介

公司代碼PLRZ
公司名稱Polyrizon Ltd
上市日期Oct 29, 2024
CEOIzraeli (Tomer)
員工數量1
證券類型Ordinary Share
年結日Oct 29
公司地址HaTidhar St. 5
城市RA'ANANA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編- -
電話97293740120
網址https://polyrizon-biotech.com/
公司代碼PLRZ
上市日期Oct 29, 2024
CEOIzraeli (Tomer)

Polyrizon Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Tomer Izraeli
Mr. Tomer Izraeli
Chief Executive Officer, Director
Chief Executive Officer, Director
6.49K
+99.88%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Director
Director
3.37K
--
Dr. Tidhar Turgeman
Dr. Tidhar Turgeman
Chief Technology Officer
Chief Technology Officer
2.92K
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
1.04K
--
Ms. Liat Sidi
Ms. Liat Sidi
Independent Director
Independent Director
1.04K
--
Mr. Yehonatan Zalman Vinokur
Mr. Yehonatan Zalman Vinokur
Independent Director
Independent Director
1.04K
--
Mr. Liron Carmel
Mr. Liron Carmel
Director
Director
522.00
--
Mr. Nir Ben Yosef
Mr. Nir Ben Yosef
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Eyal S. Ron, Ph.D.
Dr. Eyal S. Ron, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Daphna Avital
Ms. Daphna Avital
Chief People Officer
Chief People Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Tomer Izraeli
Mr. Tomer Izraeli
Chief Executive Officer, Director
Chief Executive Officer, Director
6.49K
+99.88%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Director
Director
3.37K
--
Dr. Tidhar Turgeman
Dr. Tidhar Turgeman
Chief Technology Officer
Chief Technology Officer
2.92K
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
1.04K
--
Ms. Liat Sidi
Ms. Liat Sidi
Independent Director
Independent Director
1.04K
--
Mr. Yehonatan Zalman Vinokur
Mr. Yehonatan Zalman Vinokur
Independent Director
Independent Director
1.04K
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 5月9日 週六
更新時間: 5月9日 週六
持股股東
股東類型
持股股東
持股股東
佔比
FNY Investment Advisers LLC
1.38%
Izraeli (Tomer)
0.36%
Adler (Oz)
0.21%
Turgeman (Tidhar)
0.18%
Legacy Wealth Management, LLC
0.06%
其他
97.81%
持股股東
持股股東
佔比
FNY Investment Advisers LLC
1.38%
Izraeli (Tomer)
0.36%
Adler (Oz)
0.21%
Turgeman (Tidhar)
0.18%
Legacy Wealth Management, LLC
0.06%
其他
97.81%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
1.38%
Individual Investor
0.99%
Research Firm
0.79%
Investment Advisor
0.06%
其他
96.77%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
13
39.77K
2.23%
-18.04K
2025Q4
10
1.04K
0.07%
-57.85K
2025Q3
10
370.57K
6.19%
+370.41K
2025Q2
15
715.00
0.01%
-142.00
2025Q1
18
1.04K
18.49%
+190.00
2024Q4
14
2.89M
68.88%
+2.89M

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Izraeli (Tomer)
8.00
0%
--
--
Mar 10, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
May 22, 2025
Merger
250→1
公告日期
除權除息日
類型
比率
May 22, 2025
Merger
250→1
KeyAI